EMA's safe­ty com­mit­tee rec­om­mends sus­pend­ing preterm birth drugs

The Eu­ro­pean Med­i­cines Agency is tak­ing aim at preterm birth drugs, with the agency’s safe­ty com­mit­tee rec­om­mend­ing that med­i­cines con­tain­ing 17-hy­drox­yprog­es­terone caproate, al­so known as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.